» Articles » PMID: 17090573

Chronic Obstructive Pulmonary Disease in the Older Adult: What Defines Abnormal Lung Function?

Overview
Journal Thorax
Date 2006 Nov 9
PMID 17090573
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The Global Initiative on Obstructive Lung Disease stages for chronic obstructive pulmonary disease (COPD) uses a fixed ratio of the post-bronchodilator forced expiratory volume in 1 second (FEV(1))/forced vital capacity (FVC) of 0.70 as a threshold. Since the FEV(1)/FVC ratio declines with age, using the fixed ratio to define COPD may "overdiagnose" COPD in older populations.

Objective: To determine morbidity and mortality among older adults whose FEV(1)/FVC is less than 0.70 but more than the lower limit of normal (LLN).

Methods: The severity of COPD was classified in 4965 participants aged > or =65 years in the Cardiovascular Health Study using these two methods and the age-adjusted proportion of the population who had died or had a COPD-related hospitalisation in up to 11 years of follow-up was determined.

Results: 1621 (32.6%) subjects died and 935 (18.8%) had at least one COPD-related hospitalisation during the follow-up period. Subjects (n = 1134) whose FEV(1)/FVC fell between the LLN and the fixed ratio had an increased adjusted risk of death (hazard ratio (HR) 1.3, 95% CI 1.1 to 1.5) and COPD-related hospitalisation (HR 2.6, 95% CI 2.0 to 3.3) during follow-up compared with asymptomatic individuals with normal lung function.

Conclusion: In this cohort, subjects classified as "normal" using the LLN but abnormal using the fixed ratio were more likely to die and to have a COPD-related hospitalisation during follow-up. This suggests that a fixed FEV(1)/FVC ratio of <0.70 may identify at-risk patients, even among older adults.

Citing Articles

Beyond the Spirometry: New Diagnostic Modalities in Chronic Obstructive Pulmonary Disease.

Song J, Kim Y Tuberc Respir Dis (Seoul). 2024; 88(1):1-13.

PMID: 39308278 PMC: 11704728. DOI: 10.4046/trd.2024.0040.


Much Lower Prevalence and Mortality of Chronic Obstructive Pulmonary Disease in Japan Than in the United States Despite Higher Smoking Rates: A Meta-Analysis/Systematic Review.

Sekikawa A, Li M, Joshi N, Herbert B, Tilves C, Cui C J Epidemiol. 2024; 35(2):90-99.

PMID: 39034109 PMC: 11706673. DOI: 10.2188/jea.JE20240085.


Implementation of the Care Bundle for the Management of Chronic Obstructive Pulmonary Disease with/without Heart Failure.

Bianco A, Canepa M, Catapano G, Marvisi M, Oliva F, Passantino A J Clin Med. 2024; 13(6).

PMID: 38541845 PMC: 10971568. DOI: 10.3390/jcm13061621.


Unadjusted Lower Limit of Normal for Airflow Obstruction.

Bhatt S, Bodduluri S, Nakhmani A, Oelsner E Am J Respir Crit Care Med. 2024; 209(8):1028-1030.

PMID: 38301239 PMC: 11531222. DOI: 10.1164/rccm.202312-2301LE.


Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis.

Wachami N, Guennouni M, Iderdar Y, Boumendil K, Arraji M, Mourajid Y BMC Public Health. 2024; 24(1):297.

PMID: 38273271 PMC: 10811845. DOI: 10.1186/s12889-024-17686-9.


References
1.
Celli B, MacNee W . Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004; 23(6):932-46. DOI: 10.1183/09031936.04.00014304. View

2.
Pellegrino R, Viegi G, Brusasco V, Crapo R, Burgos F, Casaburi R . Interpretative strategies for lung function tests. Eur Respir J. 2005; 26(5):948-68. DOI: 10.1183/09031936.05.00035205. View

3.
Johannessen A, Omenaas E, Bakke P, Gulsvik A . Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax. 2005; 60(10):842-7. PMC: 1747202. DOI: 10.1136/thx.2005.043943. View

4.
Chen J, Mannino D . Worldwide epidemiology of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2000; 5(2):93-9. DOI: 10.1097/00063198-199903000-00003. View

5.
Watson G . Low vision in the geriatric population: rehabilitation and management. J Am Geriatr Soc. 2001; 49(3):317-30. DOI: 10.1046/j.1532-5415.2001.4930317.x. View